We are stewards of patient capital: not day-to-day operators, not intermediaries. We take carefully considered equity positions in independently licensed and governed businesses operating in sectors where regulatory complexity is a feature, not a friction. We hold with discipline and purpose. We govern at the board level, support with strategic insight, and trust each portfolio company's own leadership to execute. What we bring is rare: long-horizon conviction, regulatory fluency, and a network built across life sciences, agricultural technology, and therapeutic innovation.

Four independently operated companies. Each a market-ready platform in its own right and each a potential point of connection for strategic partners, distributors, and co-investors.

Where durable value is built, and where the right partners find us.

We seek businesses where regulatory complexity, licensing requirements, and compliance infrastructure create barriers to entry that protect long-term equity value. We do not seek operational control. We seek well-governed, independently managed companies where our capital, board participation, and network accelerate outcomes. The same qualities that make our portfolio companies attractive to us make them attractive to the right strategic partners: distributors, co-manufacturers, licensing partners, and co-investors who understand regulated markets.

Independently licensed companies across two jurisdictions. Operational, exporting, and commercializing into four regulated global markets, with infrastructure already in place.